Related Experiment Video
Updated: Jul 8, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
[Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer]
Jian-ping Liu1, Shi-zhen Yuan, Shi-neng Zhang
1Department of Gastroenterology, Guangdong Frontier Armed Police Hospital, Shenzhen 518029, China.
Objective:
To investigate the inhibitory effect of gene silencing mediated by MAT1-siRNA constructed in vitro transcription for pancreatic cancer in vivo and in vitro.
Methods:
21-nt double strand siRNA targeting MAT1 gene was constructed and labeled with Cy3 fluorescent labeling reagent. Human pancreatic cancer cells of the line BxPC3 were cultured and divided into 4 groups: MAT1-siRNA transfected group, negative siRNA control group, lipid control group, and blank control group. The rate of cell duplication was determined by counting the cells for three consecutive days. Cell cycle profiles were determined by flow cytometry. Semi-quantitative analysis of the level of MAT1-mRNA expression was performed using the RT-PCR technique. The level of MAT1 protein expression was analyzed by Western-blotting. 18 nude mice were injected subcutaneously with BxPC3 cells to establish mouse tumor models, and then divided randomly into 3 equal groups: MAT1-siRNA group undergoing injection of MAT1-siRNA directly into the tumors 2 times a week for 4 weeks, blank control group, and negative MAT1-siRNA group. 4 weeks later the mice were killed to observe the weight and size of tumor and to calculate the tumor inhibition rate.
Results:
Two of the 4 designed MAT1-siRNAs significantly suppressed the growth of the BxPC3 cells. 72 h after transfection the cell duplication was inhibited by 34.9% in the MAT1-siRNA transfection group. The cell cycle profile showed 83.9% of the MAT1-siRNA transfected cells were in the G0/G1 phase, a rate significantly higher than that in the blank control group (59.86%, P < 0.01). 48 h later the content of MAT1-mRNA of the MAT1-siRNA transfected cells was significantly reduced by 80.12%, and 72 h after the transfection the content of MAT1 protein was reduced by 50.12%, a rate significantly higher than those of the 2 control groups (both P < 0.01). The weight and volume of the transplant tumors in the MAT1-siRNA injected nude mice were significantly reduced compare with the negative siRNA injected control nude mice and blank control nude mice (both P < 0.05). The inhibition rate was 42.53%.
Conclusion:
MAT1 gene silencing mediated by siRNA significantly suppresses the growth of pancreatic cancer cells in vitro, and significantly achieves an anti-tumor effect on the subcutaneously transplanted pancreatic tumor in vivo.
Insights
Gene silencing of MAT1 using siRNA effectively inhibits pancreatic cancer cell growth in vitro and reduces tumor size in vivo. This study demonstrates MAT1-siRNA as a potential therapeutic strategy for pancreatic cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Pancreatic cancer remains a significant global health challenge with limited effective treatments.
- Targeting specific genes involved in cancer proliferation is a promising therapeutic avenue.
Purpose of the Study:
- To investigate the efficacy of silencing the MAT1 gene using small interfering RNA (siRNA) to inhibit pancreatic cancer growth.
- To evaluate the anti-tumor effects of MAT1-siRNA in both in vitro and in vivo pancreatic cancer models.
Main Methods:
- Constructed and validated MAT1-siRNA targeting the MAT1 gene.
- Assessed pancreatic cancer cell (BxPC3) proliferation, cell cycle, and gene/protein expression after MAT1-siRNA transfection.
- Evaluated tumor growth inhibition in a nude mouse xenograft model treated with MAT1-siRNA.
Main Results:
- MAT1-siRNA significantly suppressed BxPC3 cell proliferation by 34.9% and induced G0/G1 cell cycle arrest.
- MAT1-siRNA reduced MAT1 mRNA and protein levels by 80.12% and 50.12%, respectively.
- In vivo studies showed a 42.53% tumor inhibition rate in the MAT1-siRNA group compared to controls.
Conclusions:
- MAT1 gene silencing via siRNA effectively inhibits pancreatic cancer cell growth in vitro.
- MAT1-siRNA demonstrates significant anti-tumor activity against transplanted pancreatic tumors in vivo, indicating its therapeutic potential.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...